NEW YORK (360Dx) — Evogen announced today that it has received a $224,515 grant from the National Institutes of Health to continue development of a protein biomarker-based diagnostic for epilepsy.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.